Eli Lilly and Company Price Today
Eli Lilly and Company
LLY
Healthcare
$426.69B
💰
Market Cap
71.3
💸
Price to Earnings
$6.3
🎉
EPS
+68
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
16 |
Strong Buy |
9 |
Hold |
7 |
Sell |
1 |
Strong Sell |
0 |
LLY Price Forecast Target
449.5 👉 492.9 +10%
LLY EPS Forecast
6.3 👉 10.7 +70%
Financials
Profit Margin
21 %
Revenue Growth
-10.9 %
Dividend
$ 4.52
Held Percent
0.2% - Insiders
84.0% - Institutions
15.8% - Public
Major Fund Holders
-
💰 Lilly Endowment, Inc $45.4B
-
💰 Vanguard Group Inc $31.5B
-
💰 Blackrock Inc. $29.5B
-
💰 PNC Financial Services Group, Inc. $23.3B
-
💰 State Street Corporation $14.9B
Stock Ideas
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …📮FAQ
Some Frequently Asked Questions.
The Eli Lilly and Company industry is Drug Manufacturers—General
The Eli Lilly and Company sector is Healthcare
The Eli Lilly and Company forecasted predicted Price to Earnings PE ratio is 42.0
The Eli Lilly and Company Price to Earnings PE ratio is 71.3
The Market Capitalization of Eli Lilly and Company is $426.69B
There are total of 947393373 float shares with 84.0% held by Institutions and 0.2% held by insiders
The MEli Lilly and Company forecasted Earnings per Share EPS is $10.7
The Eli Lilly and Company Earnings per Share EPS is 6.3
The Eli Lilly and Company company has $21911600000 gross profits with 21 profit margins
The Eli Lilly and Company Earnings Growth is -0.29% with -0.293% quarterly earnings growth
The Eli Lilly and Company Revenue is $27691399168 with -0.109 revenue growth
The price target for Eli Lilly and Company stock is $492.9 for the high target and $261.7 for the low target
The consensus analyst recommendations for Eli Lilly and Company is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Eli Lilly and Company is Buy, with the following breakdown:
- Buy: 16
- Strong Buy: 9
- Hold: 7
- Sell: 1
- Strong Sell: 0
The Beta of Eli Lilly and Company is 0.3
The dividend of Eli Lilly and Company is $4.52
The dividend yield of Eli Lilly and Company is 0.0101%
The biggest institutional and mutual fund holders of Eli Lilly and Company stock are
- Lilly Endowment, Inc
- Vanguard Group Inc
- Blackrock Inc.
- PNC Financial Services Group, Inc.
The Eli Lilly and Company ESG Score is 68, with the following breakdown:
- E: 3.43
- S: 17.4
- G: 11.56